Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE vs PALBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMLODIPINE vs PALBOCICLIB: Safety Overview

Metric AMLODIPINE PALBOCICLIB
Total FAERS Reports 64,924 91,024
Deaths Reported 10,161 11,066
Death Rate 15.7% 12.2%
Hospitalizations 26,787 13,442
Average Patient Age 62.8 yrs 66.0 yrs
% Female Patients 57.0% 97.7%
FDA Approval Date Apr 12, 2011 Feb 3, 2015
Manufacturer Teva Pharmaceuticals USA, Inc. Pfizer Laboratories Div Pfizer Inc
Route ORAL ORAL
Marketing Status Prescription Prescription